Literature DB >> 8238569

Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation.

L W DeBoer1, P A Bekx, L Han, L Steinke.   

Abstract

Pyruvate protects myocardium from ischemic and anoxic injury, effects that have been attributed to beneficial metabolic alterations. Pyruvate also reacts with hydrogen peroxide in vitro, and pyruvate prevents free radical injury in other organs. Hearts supplied with 2 mM of pyruvate with glucose during reperfusion recovered significantly more mechanical function (81%) than those provided with 2 mM of acetate (which does not react with free radicals) and glucose (49%) or glucose alone (27%). Pyruvate significantly reduced free radical generation during reperfusion as measured with electron spin resonance using the spin-trap 5,5-dimethyl-1-pyrroline-1-oxide. In a model of direct oxidant stress, hearts were perfused with 0.28 mM of hydrogen peroxide. In this model, loss of function was almost entirely prevented by addition of 2 mM of pyruvate. From these results we conclude an important mechanism of protection when pyruvate is supplied during reperfusion is limitation of oxygen-derived free radical damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238569     DOI: 10.1152/ajpheart.1993.265.5.H1571

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Proceedings of the scientific meetings of the Physiology Society. November 1996 and January 1997. Abstracts.

Authors: 
Journal:  J Physiol       Date:  1997-02       Impact factor: 5.182

2.  Effect of peritoneal dialysis solution with different pyruvate concentrations on intestinal injury.

Authors:  Jing-Jing Zhang; Hui-Qin Shen; Jiang-Tao Deng; Lin-Lin Jiang; Qiong-Yue Zhang; Ying Xiong; Zong-Ze Zhang; Yan-Lin Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-12

3.  Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart.

Authors:  M M Awan; S Makaula; S Forresti; M N Sack; L H Opie
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

4.  Oxidant stress and damage in post-ischemic mouse hearts: effects of adenosine.

Authors:  Benjamin Hack; Paul K Witting; Benjamin S Rayner; Roland Stocker; John P Headrick
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

5.  Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expression.

Authors:  Ben M Tsai; Tim Lahm; Eric D Morrell; Paul R Crisostomo; Jeffrey Poynter; Meijing Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

Review 6.  Erythropoietin: powerful protection of ischemic and post-ischemic brain.

Authors:  Anh Q Nguyen; Brandon H Cherry; Gary F Scott; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

7.  Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.

Authors:  Jhudit Pérez-Escuredo; Rajesh K Dadhich; Suveera Dhup; Andrea Cacace; Vincent F Van Hée; Christophe J De Saedeleer; Martina Sboarina; Fabien Rodriguez; Marie-Joséphine Fontenille; Lucie Brisson; Paolo E Porporato; Pierre Sonveaux
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  The influence of lactate, pyruvate and glucose as exogenous substrates on free radical defense mechanisms in isolated rat hearts during ischaemia and reperfusion.

Authors:  M J de Groot; M A van Helden; Y F de Jong; W A Coumans; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1995-05-24       Impact factor: 3.396

Review 9.  Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate.

Authors:  Xuemei Li; Junwu Su; Xizhong Cui; Yan Li; Amisha Barochia; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2009-08       Impact factor: 6.206

10.  The positive inotropic effect of pyruvate involves an increase in myofilament calcium sensitivity.

Authors:  Carlos A A Torres; Kenneth D Varian; Cynthia H Canan; Jonathan P Davis; Paul M L Janssen
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.